Subscribe

Shannon Hogan, PharmD

Albany College of Pharmacy and Health Sciences—Vermont Campus
Colchester, Vermont

Authored Items

New Developments in the Management of Hand-Foot Syndrome Associated With Oral Anti-VEGF Tyrosine Kinase Inhibitor–Targeted Anticancer Therapies
By Joanna Schwartz, PharmD, BCOP; Shannon Hogan, PharmD
TON - April 2013, Vol 6, No 3
Supportive Care
Hand-foot skin reaction (HFSR), also known as hand-foot syndrome or palmar-plantar erythrodysesthesia (PPE), is an adverse effect of several chemotherapeutic agents.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, TON print publication, and TON Bi-Weekly e‑newsletter.

Subscribe

Amplity

© Amplity, Inc. All Rights Reserved. Privacy Policy.